ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Ties Up With Biocon Unit To Develop Nutrition Products In India

BANGALORE -(Dow Jones)- U.S. drug maker Abbott Laboratories (ABT) has tied up with a unit of Indian biotechnology company Biocon Ltd. (532523.BY) to set up a research and development center for nutrition products. Abbott will set up the center in India in collaboration with Biocon's contract research unit, Syngene. More than 50 researchers and scientists will be based at the center, which is expected to open in June, the companies said in a joint statement Thursday. Syngene currently has a research tie-up with Bristol-Myers Squibb Co., under which it provides research and development services for the company's discovery and early drug development processes. -By Rumman Ahmed, Dow Jones Newswires; 91-9845104173; [email protected]

Stock News for Abbott Labs (ABT)
DateTimeHeadline
01/20/201718:00:00New Study Demonstrates Spinal Cord Stimulation Can Reduce or...
01/19/201717:26:26Amended Statement of Ownership (sc 13g/a)
01/18/201708:00:00Abbott Announces European Launch of the Proclaim™ DRG Neurostimulation S...
01/17/201708:00:00New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers...
01/13/201702:19:08Aqua Bio Technology enters new technology partnership
01/12/201716:00:00Abbott Announces U.S. Launch and First Commercial Use of the...
01/12/201704:01:29Aqua Bio Technology enters into New Zealand partnership
01/12/201702:50:32Aqua Bio Technology expands product portfolio
01/11/201702:00:31ABT expands business model
01/10/201707:00:00Abbott Announces CE Mark for its Alinity ci-series Diagnostic...
01/10/201707:00:00Abbott Announces CE Mark for its "Alinity s" Blood and Plasma...
01/10/201707:00:00Abbott Announces CE Mark for its Alinity ci-series Diagnostic...
01/10/201707:00:00Abbott Announces CE Mark for its "Alinity s" Blood and Plasma...
01/09/201717:33:00Abbott's St. Jude Patches Device Software After Regulators Confirm...
01/08/201715:11:00Parkinson's Therapy Gets Fresh Look From Device Makers
01/08/201715:10:00Parkinson's Therapy Gets Fresh Look From Device Makers
01/08/201707:29:00Parkinson's Therapy Gets Fresh Look From Device Makers
01/06/201717:30:20Statement of Changes in Beneficial Ownership (4)
01/06/201717:30:20Statement of Changes in Beneficial Ownership (4)
01/06/201717:27:47Initial Statement of Beneficial Ownership (3)

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US